Hangzhou Coco Healthcare Products Stock Forecast for 2023 - 2025 - 2030

Updated on 05/09/2024

Stock Rating
14
Price Target
¥14.80
Consensus
Outperform
Upside
68.76%
Analysts
0
Stock Rating
14
Upside
68.76%
Analysts
0
Price Target
¥14.80

Hangzhou Coco Healthcare Products Stock Forecast and Price Target

The average price target for Hangzhou Coco Healthcare Products's stock of ¥14.80 recently provided by leading analysts would represent a 68.76% upside from its last closing price if reached. This potential increase is based on a high estimate of ¥14.80 and a low estimate of ¥14.80.

¥14.80

68.76% Upside

Buy
Buy

Hangzhou Coco Healthcare Products Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Hangzhou Coco Healthcare Products's Price has fallen from ¥2.10 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
¥0.00
2026 Fair Value Forecast
¥0.00
2027 Fair Value Forecast
¥0.00
2028 Fair Value Forecast
¥0.00
2029 Fair Value Forecast
¥0.00
2030 Fair Value Forecast
¥0.00

Hangzhou Coco Healthcare Products Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Hangzhou Coco Healthcare Products's Revenue has fallen from ¥1.64B to ¥1.19B – a 27.45% decrease. In the next year, analysts believe that Revenue will reach ¥1.34B – an increase of 12.61%. For the next eight years, the forecast is for Revenue to grow by 13.21%.

2023 Rev Forecast
¥1.34B
2024 Rev Forecast
¥1.45B
2025 Rev Forecast
¥1.36B
2026 Rev Forecast
¥1.30B
2027 Rev Forecast
¥1.32B
2028 Rev Forecast
¥1.36B
2029 Rev Forecast
¥1.36B
2030 Rev Forecast
¥1.34B

Hangzhou Coco Healthcare Products Dividend per Share Forecast for 2023 - 2025 - 2030

Hangzhou Coco Healthcare Products Free Cash Flow Forecast for 2023 - 2025 - 2030

Hangzhou Coco Healthcare Products EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Hangzhou Coco Healthcare Products's EBITDA has decreased from ¥348.23M to ¥18.53M – a 94.68% drop. Analysts predict that Hangzhou Coco Healthcare Products's EBITDA will increase in the upcoming year, reaching ¥81.07M. This would represent an increase of 337.51%. Over the next eight years, experts predict that Hangzhou Coco Healthcare Products's EBITDA will grow at a rate of 1324.38%.

2023 EBITDA Forecast
¥0.08B
2024 EBITDA Forecast
¥0.24B
2025 EBITDA Forecast
¥0.40B
2026 EBITDA Forecast
¥0.16B
2027 EBITDA Forecast
¥0.18B
2028 EBITDA Forecast
¥0.25B
2029 EBITDA Forecast
¥0.34B
2030 EBITDA Forecast
¥0.26B

Hangzhou Coco Healthcare Products EBIT Forecast for 2023 - 2025 - 2030

Hangzhou Coco Healthcare Products's EBIT has decreased by 113.32% In the last two years, from ¥309.30M to ¥-41.21M. In the next year, analysts believe that EBIT will reach ¥-202.82M – an increase of 392.16%. For the next eight years, the forecast is forEBIT to grow by 1429.79%.

2023 EBIT Forecast
¥-202817762.33
2024 EBIT Forecast
¥-821060386.66
2025 EBIT Forecast
¥-895858987.89
2026 EBIT Forecast
¥-408123492.91
2027 EBIT Forecast
¥-456907854.43
2028 EBIT Forecast
¥-609941525.15
2029 EBIT Forecast
¥-780196536.20
2030 EBIT Forecast
¥-630424807.80

Hangzhou Coco Healthcare Products EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Hangzhou Coco Healthcare Products's EPS has fallen from ¥0.14 to ¥0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
¥0.00
2026 EPS Forecast
¥0.00
2027 EPS Forecast
¥0.00
2028 EPS Forecast
¥0.00
2029 EPS Forecast
¥0.00
2030 EPS Forecast
¥0.00